# Effect of CSII and CGM on Progression of Late Diabetic Complications

> **NCT01454700** · PHASE4 · COMPLETED · sponsor: **Steen Andersen** · enrollment: 60 (actual)

## Conditions studied

- Type 1 Diabetes Mellitus

## Interventions

- **DEVICE:** Insulin pump therapy (CSII) plus continuous glucose monitoring (CGM)
- **OTHER:** Multiple daily insulin injections (MDI)

## Key facts

- **NCT ID:** NCT01454700
- **Lead sponsor:** Steen Andersen
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-12
- **Primary completion:** 2014-12
- **Final completion:** 2014-12
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2015-01-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01454700

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01454700, "Effect of CSII and CGM on Progression of Late Diabetic Complications". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT01454700. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
